144 related articles for article (PubMed ID: 23187686)
1. Cytotoxic effect and molecular docking of 4-ethoxycarbonylmethyl-1-(piperidin-4-ylcarbonyl)-thiosemicarbazide--a novel topoisomerase II inhibitor.
Siwek A; Stączek P; Wujec M; Bielawski K; Bielawska A; Paneth P
J Mol Model; 2013 Mar; 19(3):1319-24. PubMed ID: 23187686
[TBL] [Abstract][Full Text] [Related]
2. Search for human DNA topoisomerase II poisons in the group of 2,5-disubstituted-1,3,4-thiadiazoles.
Plech T; Kaproń B; Paneth A; Wujec M; Czarnomysy R; Bielawska A; Bielawski K; Trotsko N; Kuśmierz E; Paneth P
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):1021-6. PubMed ID: 25792499
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.
Siwek A; Bielawska A; Maciorkowska E; Lepiarczyk M; Bielawski K; Trotsko N; Wujec M
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):243-8. PubMed ID: 23432612
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in silico assessment of DNA interaction, topoisomerase I and II inhibition properties of chrysosplenetin.
Şöhretoğlu D; Barut B; Sari S; Özel A; Arroo R
Int J Biol Macromol; 2020 Nov; 163():1053-1059. PubMed ID: 32673727
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel topoisomerase II alpha inhibitors by virtual screening, molecular docking, and bioassay.
Yu C; Hu J; Luyten W; Sun D; Jiang T
Chem Biol Drug Des; 2022 Jan; 99(1):92-102. PubMed ID: 34310071
[TBL] [Abstract][Full Text] [Related]
6. Dual Antibacterial and Anticancer Activity of 4-Benzoyl-1-dichlorobenzoylthiosemicarbazide Derivatives.
Kapron B; Czarnomysy R; Paneth A; Wujec M; Bielawski K; Bielawska A; Swiatek L; Rajtar B; Polz-Dacewicz M; Plech T
Anticancer Agents Med Chem; 2018; 18(4):529-540. PubMed ID: 29065843
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
8. Triphenylethylene analogues: Design, synthesis and evaluation of antitumor activity and topoisomerase inhibitors.
Rani S; Paul K
Eur J Med Chem; 2020 Dec; 208():112775. PubMed ID: 32898794
[TBL] [Abstract][Full Text] [Related]
9. Computational studies, design and synthesis of Pd(II)-based complexes: Allosteric inhibitors of the Human Topoisomerase-IIα.
Rocha FV; Farias RL; Lima MA; Batista VS; Nascimento-Júnior NM; Garrido SS; Leopoldino AM; Goto RN; Oliveira AB; Beck J; Landvogt C; Mauro AE; Netto AVG
J Inorg Biochem; 2019 Oct; 199():110725. PubMed ID: 31374424
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors.
Paneth A; Stączek P; Plech T; Strzelczyk A; Dzitko K; Wujec M; Kuśmierz E; Kosikowska U; Grzegorczyk A; Paneth P
J Enzyme Inhib Med Chem; 2016; 31(1):14-22. PubMed ID: 25792505
[TBL] [Abstract][Full Text] [Related]
12. 4-(1,2-diarylbut-1-en-1-yl)isobutyranilide derivatives as inhibitors of topoisomerase II.
Christodoulou MS; Zarate M; Ricci F; Damia G; Pieraccini S; Dapiaggi F; Sironi M; Lo Presti L; García-Argáez AN; Dalla Via L; Passarella D
Eur J Med Chem; 2016 Aug; 118():79-89. PubMed ID: 27128175
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
[TBL] [Abstract][Full Text] [Related]
14. (S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells.
Hikita K; Yamakage Y; Okunaga H; Motoyama Y; Matsuyama H; Matsuoka K; Murata T; Nakayoshi T; Oda A; Kato K; Tanaka H; Asao N; Dan S; Kaneda N
Bioorg Med Chem; 2021 Jan; 30():115904. PubMed ID: 33341500
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Human Topoisomerase II by N,N,N-Trimethylethanammonium Iodide Alkylcarbazole Derivatives.
Saturnino C; Caruso A; Iacopetta D; Rosano C; Ceramella J; Muià N; Mariconda A; Bonomo MG; Ponassi M; Rosace G; Sinicropi MS; Longo P
ChemMedChem; 2018 Dec; 13(24):2635-2643. PubMed ID: 30347518
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors.
El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Khalifa MM; Belal A; Rashed M; El-Sharkawy A; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Eissa IH
Bioorg Chem; 2020 Oct; 103():104233. PubMed ID: 32882440
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
18. New fused pyrimidine derivatives with anticancer activity: Synthesis, topoisomerase II inhibition, apoptotic inducing activity and molecular modeling study.
Nemr MTM; AboulMagd AM
Bioorg Chem; 2020 Oct; 103():104134. PubMed ID: 32750610
[TBL] [Abstract][Full Text] [Related]
19. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
